KR102204578B1 - 알카프타딘 및 이의 약제학적으로 허용가능한 염의 제조 방법 - Google Patents

알카프타딘 및 이의 약제학적으로 허용가능한 염의 제조 방법 Download PDF

Info

Publication number
KR102204578B1
KR102204578B1 KR1020157030845A KR20157030845A KR102204578B1 KR 102204578 B1 KR102204578 B1 KR 102204578B1 KR 1020157030845 A KR1020157030845 A KR 1020157030845A KR 20157030845 A KR20157030845 A KR 20157030845A KR 102204578 B1 KR102204578 B1 KR 102204578B1
Authority
KR
South Korea
Prior art keywords
acid
formula
salt
alcaptadine
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020157030845A
Other languages
English (en)
Korean (ko)
Other versions
KR20160018472A (ko
Inventor
안토니오 로렌테 본데-라르센
제수스 미구엘 이글레시아스 레투에르토
프랑시소 자비에르 갈로 니에토
주안 조세 페레이로 길
Original Assignee
크리스탈 파마 에스.에이.유.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 크리스탈 파마 에스.에이.유. filed Critical 크리스탈 파마 에스.에이.유.
Publication of KR20160018472A publication Critical patent/KR20160018472A/ko
Application granted granted Critical
Publication of KR102204578B1 publication Critical patent/KR102204578B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
KR1020157030845A 2013-03-25 2014-03-24 알카프타딘 및 이의 약제학적으로 허용가능한 염의 제조 방법 Active KR102204578B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13160829 2013-03-25
EP13160829.1 2013-03-25
PCT/EP2014/055815 WO2014154620A1 (en) 2013-03-25 2014-03-24 Methods for the preparation of alcaftadine

Publications (2)

Publication Number Publication Date
KR20160018472A KR20160018472A (ko) 2016-02-17
KR102204578B1 true KR102204578B1 (ko) 2021-01-20

Family

ID=47913271

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020157030845A Active KR102204578B1 (ko) 2013-03-25 2014-03-24 알카프타딘 및 이의 약제학적으로 허용가능한 염의 제조 방법

Country Status (7)

Country Link
US (1) US9682984B2 (https=)
EP (1) EP2978765B1 (https=)
JP (1) JP6400672B2 (https=)
KR (1) KR102204578B1 (https=)
CA (1) CA2907396C (https=)
ES (1) ES2680933T3 (https=)
WO (1) WO2014154620A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104860920B (zh) * 2015-04-15 2017-08-25 武汉武药科技有限公司 一种阿卡他定中间体的制备方法
CN104987337B (zh) * 2015-07-28 2018-01-12 武汉武药科技有限公司 一种制备阿卡他定的氧化方法
US11951165B2 (en) 2016-12-30 2024-04-09 Vaxcyte, Inc. Conjugated vaccine carrier proteins
ES3024474T3 (en) 2016-12-30 2025-06-04 Vaxcyte Inc Polypeptide-antigen conjugates with non-natural amino acids

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034897A1 (en) 1996-03-19 1997-09-25 Janssen Pharmaceutica N.V. Fused imidazole derivatives as multidrug resistance modulators
US20080139531A1 (en) 2006-12-04 2008-06-12 Alcon Manufacturing Ltd. Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair
WO2014083571A1 (en) 2012-11-29 2014-06-05 Neuland Laboratories Limited A process for the preparation of alcaftadine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070381A (en) * 1972-07-12 1978-01-24 Lever Brothers Company Certain 2-(hydroxyalkyl)-2,5-dialkyl-4-hydroxy-4,5-dihydrofuran-3-ones and method for their preparation
IL101850A (en) * 1991-06-13 1996-01-31 Janssen Pharmaceutica Nv 11-(4-Piperidinyl)-imidazo (2,1-b) (3) benzazepine derivatives their preparation and pharmaceutical compositions containing them

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997034897A1 (en) 1996-03-19 1997-09-25 Janssen Pharmaceutica N.V. Fused imidazole derivatives as multidrug resistance modulators
US20080139531A1 (en) 2006-12-04 2008-06-12 Alcon Manufacturing Ltd. Use of connective tissue mast cell stabilizers to facilitate ocular surface re-epithelization and wound repair
WO2014083571A1 (en) 2012-11-29 2014-06-05 Neuland Laboratories Limited A process for the preparation of alcaftadine

Also Published As

Publication number Publication date
CA2907396A1 (en) 2014-10-02
US9682984B2 (en) 2017-06-20
ES2680933T3 (es) 2018-09-11
JP2016515555A (ja) 2016-05-30
JP6400672B2 (ja) 2018-10-03
KR20160018472A (ko) 2016-02-17
EP2978765B1 (en) 2018-05-02
US20160280709A1 (en) 2016-09-29
CA2907396C (en) 2021-11-02
EP2978765A1 (en) 2016-02-03
WO2014154620A1 (en) 2014-10-02

Similar Documents

Publication Publication Date Title
AU2010323116B2 (en) 4-[2-[[5-methyl-1-(2-naphtalenyl)-1H-pyrazol-3-yl]oxy]ethyl]morpholine salts
JP7795485B2 (ja) ピリミジニル-3,8-ジアザビシクロ[3.2.1]オクタニルメタノン誘導体およびその塩の調製
JP6389174B2 (ja) 化学的方法
US7923558B2 (en) Method for obtaining pure tetrahydrocannabinol
RS49653B (sr) Postupak za dobijanje sildenafila
EP3580219A1 (en) Process for the preparation of remimazolam and solid state forms of remimazolam salts
KR102204578B1 (ko) 알카프타딘 및 이의 약제학적으로 허용가능한 염의 제조 방법
US5276041A (en) Oxime derivatives
KR20180022125A (ko) 디아민 유도체의 산부가염 및 이의 제조 방법
CA2938023C (en) Procedure for the preparation of abiraterone acetate and intermediates thereof
WO2014005601A1 (en) A process for the preparation of solifenacin or a salt thereof
US11286254B2 (en) Process for the synthesis of 2-benzhydryl-3 quinuclidinone
CN114478536A (zh) 四氢吡嗪稠环衍生物的制备方法
Kukla et al. Polycyclic heterocycles from glutaraldehyde in one reaction
HARADA et al. New Route to 1, 3, 3a, 8a-Tetrahydro-2H-benzofuro [2, 3-b] pyrrol-2-ones from Methyl α-Hydroxy-4H-1, 2-benzoxazine-4-acetates Obtained by Ring Transformation of 4-Aryl-2-isoxazoline 2-Oxides
EP0949247B1 (en) Process for the preparation of piperidinylidene derivatives
CN114105862A (zh) 盐酸多奈哌齐杂质及其制备方法
HARADA et al. Transformation of 4-Aryl-2-isoxazoline 2-0xides”
原田和穂 et al. Synthetic Reactions of Isoxazoline 2-oxides. Part XIV. New Route to 1, 3, 3a, 8a-Tetrahydro-2H-benzofuro (2, 3-b) pyrrol-2-ones from Methyl. ALPHA.-Hydroxy-4H-1, 2-benzoxazine-4-acetates Obtained by Ring Transformation of 4-Aryl-2-isoxazoline 2-Oxides.
WO2019168025A1 (ja) モルヒナン誘導体の製造方法
JPH07133258A (ja) 2,5−ピロリジンジオン誘導体
JPH0748367A (ja) ビシクロアミン誘導体
JP2008543761A (ja) 3−アミノ−4−置換ピラゾール誘導体の合成
JP2014185091A (ja) 3−アミン−4−ピペリドン誘導体の製造方法
WO2018025295A1 (en) Concise process for preparing 3-pyrrolidine carboxylic acid derivatives

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

P22-X000 Classification modified

St.27 status event code: A-2-2-P10-P22-nap-X000

A201 Request for examination
PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902

R17-X000 Change to representative recorded

St.27 status event code: A-3-3-R10-R17-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

St.27 status event code: A-1-2-D10-D22-exm-PE0701

GRNT Written decision to grant
PR0701 Registration of establishment

St.27 status event code: A-2-4-F10-F11-exm-PR0701

PR1002 Payment of registration fee

St.27 status event code: A-2-2-U10-U12-oth-PR1002

Fee payment year number: 1

PG1601 Publication of registration

St.27 status event code: A-4-4-Q10-Q13-nap-PG1601

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 4

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 5

PR1001 Payment of annual fee

St.27 status event code: A-4-4-U10-U11-oth-PR1001

Fee payment year number: 6

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-OTH-PR1001 (AS PROVIDED BY THE NATIONAL OFFICE)

Year of fee payment: 6

PN2301 Change of applicant

St.27 status event code: A-5-5-R10-R13-asn-PN2301

St.27 status event code: A-5-5-R10-R11-asn-PN2301

R11 Change to the name of applicant or owner or transfer of ownership requested

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R11-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)

R13 Change to the name of applicant or owner recorded

Free format text: ST27 STATUS EVENT CODE: A-5-5-R10-R13-ASN-PN2301 (AS PROVIDED BY THE NATIONAL OFFICE)